Cargando…
Tissue plasminogen activator mediates deleterious complement cascade activation in stroke
The use of intravenous tissue plasminogen activator (tPA) in the treatment of ischemic stroke is limited by its propensity to exacerbate brain edema and hemorrhage. The mechanisms underlying these deleterious effects of tPA remain incompletely understood. The purpose of this study was to delineate a...
Autores principales: | Zhao, Xue-Jun, Larkin, Timothy M., Lauver, Molly A., Ahmad, Saif, Ducruet, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507253/ https://www.ncbi.nlm.nih.gov/pubmed/28700732 http://dx.doi.org/10.1371/journal.pone.0180822 |
Ejemplares similares
-
The complement cascade as a mediator of tissue growth and regeneration
por: Rutkowski, Martin J., et al.
Publicado: (2010) -
Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
por: Filatov, Asia, et al.
Publicado: (2021) -
Minor Role of Plasminogen in Complement Activation on Cell Surfaces
por: Hyvärinen, Satu, et al.
Publicado: (2015) -
Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
por: Ganti, Latha, et al.
Publicado: (2022) -
Therapeutic Modulation of the Complement Cascade in Stroke
por: Clarke, Alison R., et al.
Publicado: (2019)